| Year |
Citation |
Score |
| 2019 |
Ding Y, Zhao J, Zhang X, Wang S, Viola KL, Chow FE, Zhang Y, Lippa C, Klein WL, Gong Y. Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease. Frontiers in Neurology. 10: 1140. PMID 31736856 DOI: 10.3389/Fneur.2019.01140 |
0.312 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Lippa C, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.377 |
|
| 2018 |
Pottier C, Zhou X, Perkerson RB, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, ... ... Lippa CF, et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. The Lancet. Neurology. PMID 29724592 DOI: 10.1016/S1474-4422(18)30126-1 |
0.341 |
|
| 2017 |
Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A, Matchett BJ, Mittag T, Temirov J, Hsiung GR, Krieger C, ... ... Lippa C, et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 95: 808-816.e9. PMID 28817800 DOI: 10.1016/J.Neuron.2017.07.025 |
0.32 |
|
| 2017 |
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, ... ... Lippa C, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058 |
0.392 |
|
| 2017 |
Xu L, Ren Z, Chow FE, Tsai R, Liu T, Rizzolio F, Boffo S, Xu Y, Huang S, Lippa CF, Gong Y. Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease. Neural Plasticity. 2017: 3270725. PMID 28458925 DOI: 10.1155/2017/3270725 |
0.343 |
|
| 2016 |
Nassar BR, Lippa CF. Idiopathic Normal Pressure Hydrocephalus: A Review for General Practitioners. Gerontology and Geriatric Medicine. 2. PMID 28138494 DOI: 10.1177/2333721416643702 |
0.33 |
|
| 2016 |
Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, et al. Arguing against the proposed definition changes of PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27492190 DOI: 10.1002/Mds.26721 |
0.355 |
|
| 2015 |
Lippa CF. Medical Insurance Coverage and Alzheimer Disease. Jama Neurology. 72: 1231-1231. PMID 26348001 DOI: 10.1001/Jamaneurol.2015.2147 |
0.341 |
|
| 2015 |
Pervin F, Edwards C, Lippa CF. Dementia With Lew Body: Impacts of Surgery. American Journal of Alzheimer's Disease and Other Dementias. PMID 26006790 DOI: 10.1177/1533317515581704 |
0.322 |
|
| 2015 |
Lippa CF. Alzheimer's disease: a financial crisis and the Commonwealth of Pennsylvania. American Journal of Alzheimer's Disease and Other Dementias. 30: 117-8. PMID 25801504 DOI: 10.1177/1533317515575941 |
0.394 |
|
| 2015 |
Gong Y, Lippa C, Ong E. The pathological role of ptpa at the synapse in Alzheimer's disease Alzheimers & Dementia. 11: 774. DOI: 10.1016/J.Jalz.2015.06.1726 |
0.391 |
|
| 2014 |
Gonzalez EW, Polansky M, Lippa CF, Gitlin LN, Zauszniewski JA. Enhancing resourcefulness to improve outcomes in family caregivers and persons with Alzheimer's disease: a pilot randomized trial. International Journal of Alzheimer's Disease. 2014: 323478. PMID 25328754 DOI: 10.1155/2014/323478 |
0.316 |
|
| 2014 |
van Blitterswijk M, Mullen B, Wojtas A, Heckman MG, Diehl NN, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, ... ... Lippa C, et al. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Molecular Neurodegeneration. 9: 38. PMID 25239657 DOI: 10.1186/1750-1326-9-38 |
0.346 |
|
| 2014 |
van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, ... ... Lippa C, et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiology of Aging. 35: 2421.e13-7. PMID 24866401 DOI: 10.1016/J.Neurobiolaging.2014.04.016 |
0.324 |
|
| 2014 |
Bowen KJ, Gonzalez EW, Edwards CY, Lippa CF. Needs assessments of memory disorder patients. American Journal of Alzheimer's Disease and Other Dementias. 29: 667-72. PMID 24851872 DOI: 10.1177/1533317514534952 |
0.317 |
|
| 2014 |
Nygaard HB, Lippa CF, Mehdi D, Baehring JM. A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features. American Journal of Alzheimer's Disease and Other Dementias. 29: 433-435. PMID 24463146 DOI: 10.1177/1533317513518653 |
0.383 |
|
| 2014 |
Chow F, Gong Y, Lippa CF. The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition. American Journal of Alzheimer's Disease and Other Dementias. PMID 24421411 DOI: 10.1177/1533317513518645 |
0.344 |
|
| 2014 |
van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, ... ... Lippa C, et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica. 127: 397-406. PMID 24385136 DOI: 10.1007/S00401-013-1240-4 |
0.346 |
|
| 2014 |
Lippa CF. Imaging and Neuropsychological Correlates of Cognitive and Behavioral Symptoms in Alzheimer’s Disease American Journal of Alzheimers Disease and Other Dementias. 29: 109-110. DOI: 10.1177/1533317514523875 |
0.309 |
|
| 2013 |
Ghosh S, Libon D, Lippa C. Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm. American Journal of Alzheimer's Disease and Other Dementias. PMID 24370618 DOI: 10.1177/1533317513517040 |
0.36 |
|
| 2013 |
Lippa CF. Potential interventions and other considerations for patients with Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 28: 658-9. PMID 24234764 DOI: 10.1177/1533317513511885 |
0.394 |
|
| 2013 |
Ghosh S, Lippa CF. Clinical Subtypes of Frontotemporal Dementia. American Journal of Alzheimer's Disease and Other Dementias. PMID 23813692 DOI: 10.1177/1533317513494442 |
0.409 |
|
| 2013 |
Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL, Caselli R, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Molecular Neurodegeneration. 8: 19. PMID 23800361 DOI: 10.1186/1750-1326-8-19 |
0.41 |
|
| 2013 |
Lippa CF. Alzheimer's disease, mild cognitive impairment, and subjective memory loss. American Journal of Alzheimers Disease and Other Dementias. 28: 721-722. DOI: 10.1177/1533317513517973 |
0.371 |
|
| 2013 |
Lippa CF. Evaluation and Management of Patients With Dementia American Journal of Alzheimers Disease and Other Dementias. 28: 421-422. DOI: 10.1177/1533317513498148 |
0.333 |
|
| 2013 |
Lippa CF. Alzheimer’s Disease Topics Related to Assessment and Intervention American Journal of Alzheimers Disease and Other Dementias. 28: 214-215. DOI: 10.1177/1533317513486226 |
0.304 |
|
| 2013 |
Chow F, Lippa CF, Gong Y. Pathogenic role of Pin1 in synaptic dysfunction in Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1408 |
0.36 |
|
| 2012 |
Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, et al. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiology of Aging. 33: 2950.e5-7. PMID 22840558 DOI: 10.1016/J.Neurobiolaging.2012.07.005 |
0.345 |
|
| 2012 |
Rogers BS, Lippa CF. A clinical approach to early-onset inheritable dementia. American Journal of Alzheimer's Disease and Other Dementias. 27: 154-61. PMID 22573281 DOI: 10.1177/1533317512444000 |
0.433 |
|
| 2012 |
Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, ... ... Lippa CF, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics. 21: 3500-12. PMID 22556362 DOI: 10.1093/Hmg/Dds161 |
0.403 |
|
| 2012 |
Eppig J, Wambach D, Nieves C, Price CC, Lamar M, Delano-Wood L, Giovannetti T, Bettcher BM, Penney DL, Swenson R, Lippa C, Kabasakalian A, Bondi MW, Libon DJ. Dysexecutive functioning in mild cognitive impairment: derailment in temporal gradients. Journal of the International Neuropsychological Society : Jins. 18: 20-8. PMID 22014116 DOI: 10.1017/S1355617711001238 |
0.303 |
|
| 2012 |
Chow F, Tsai R, Lippa C, Gong Y. Peptidyl-Prolyl Isomerase Pin1: A Common Therapeutic Target for Synaptic Dysfunction and Protein Misfolding in Alzheimer's Disease (SC02.008) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Sc02.008 |
0.353 |
|
| 2012 |
Lippa CF. Family Caregiver Issues in Dementia: Dealing With Children American Journal of Alzheimers Disease and Other Dementias. 27: 561-562. DOI: 10.1177/1533317512466626 |
0.314 |
|
| 2012 |
Lippa CF. New Assessment Scales and Care Strategies for the Dementia Patient American Journal of Alzheimers Disease and Other Dementias. 27: 461-462. DOI: 10.1177/1533317512462176 |
0.304 |
|
| 2012 |
Lippa CF. Issues in the Diagnosis and Management of Alzheimer’s Disease: American Journal of Alzheimers Disease and Other Dementias. 27: 293-294. DOI: 10.1177/1533317512452813 |
0.304 |
|
| 2012 |
Lippa CF. Diagnostics and Interventions for Dementia American Journal of Alzheimers Disease and Other Dementias. 27: 221-222. DOI: 10.1177/1533317512450115 |
0.338 |
|
| 2012 |
Lippa CF. Coping With Behavior Problems in Patients With Dementia American Journal of Alzheimers Disease and Other Dementias. 27: 149-150. DOI: 10.1177/1533317512446894 |
0.323 |
|
| 2012 |
Lippa CF. Aggression in Patients with Dementia American Journal of Alzheimers Disease and Other Dementias. 27: 9-9. DOI: 10.1177/1533317512440369 |
0.386 |
|
| 2011 |
Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, ... Lippa C, et al. Ataxin-2 repeat-length variation and neurodegeneration. Human Molecular Genetics. 20: 3207-12. PMID 21610160 DOI: 10.1093/Hmg/Ddr227 |
0.358 |
|
| 2011 |
Lippa CF, Grossman M. Uplifting news for frontotemporal dementia: The sagging brain syndrome. Neurology. 76: 1370-1. PMID 21502594 DOI: 10.1212/Wnl.0B013E3182167175 |
0.322 |
|
| 2011 |
Lippa CF. Outside Influences in Dementia: The Impact of Thiamine and Atrial Fibrillation on Cognition: American Journal of Alzheimers Disease and Other Dementias. 26: 586-587. DOI: 10.1177/1533317511435730 |
0.339 |
|
| 2011 |
Lippa CF. Brain Donation and the Dementia Family: What Factors Impact Participation? American Journal of Alzheimers Disease and Other Dementias. 26: 435-436. DOI: 10.1177/1533317511427074 |
0.31 |
|
| 2011 |
Lippa CF. Diagnosing and Managing Alzheimer’s Disease, Distinguishing Posterior Variants of Dementia and the Usefulness of Exercise American Journal of Alzheimers Disease and Other Dementias. 26: 355-356. DOI: 10.1177/1533317511419728 |
0.332 |
|
| 2011 |
Lippa CF. Review of Issue: Institutionalizing Patients With Dementia American Journal of Alzheimers Disease and Other Dementias. 26: 167-168. DOI: 10.1177/1533317511405983 |
0.375 |
|
| 2011 |
Lippa CF. Review of Issue: Veterans With Dementia: Diagnosis, Intervention, Resources, and Communication American Journal of Alzheimers Disease and Other Dementias. 26: 91-92. DOI: 10.1177/1533317511400892 |
0.316 |
|
| 2010 |
Gong Y, Lippa CF. Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. American Journal of Alzheimer's Disease and Other Dementias. 25: 547-55. PMID 20858652 DOI: 10.1177/1533317510382893 |
0.384 |
|
| 2010 |
Lippa CF. Review of issue: the impact of time of day, mood, and caregiver stress on function in patients with dementia. American Journal of Alzheimer's Disease and Other Dementias. 25: 475-6. PMID 20819902 DOI: 10.1177/1533317510382487 |
0.326 |
|
| 2010 |
Lippa CF. Review of issue: cognitive impairment in Parkinson's disease. American Journal of Alzheimer's Disease and Other Dementias. 25: 387-8. PMID 20660516 DOI: 10.1177/1533317510374052 |
0.364 |
|
| 2010 |
Lippa CF, Chetelat G. Tarot decks and PET scans: predicting the future of MCI. Neurology. 75: 204-5. PMID 20592256 DOI: 10.1212/Wnl.0B013E3181E8E91B |
0.385 |
|
| 2010 |
Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: caregiver burden and unmet needs. Alzheimer Disease and Associated Disorders. 24: 177-81. PMID 20505434 DOI: 10.1097/Wad.0B013E3181C72B5D |
0.362 |
|
| 2010 |
Lippa CF. Review of issue: changing environment and activities for the patients with dementia: what can we do to ease the burden? American Journal of Alzheimer's Disease and Other Dementias. 25: 187-8. PMID 20439920 DOI: 10.1177/1533317510366523 |
0.349 |
|
| 2010 |
Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism & Related Disorders. 16: 388-92. PMID 20434939 DOI: 10.1016/J.Parkreldis.2010.03.007 |
0.371 |
|
| 2010 |
Lippa CF. Interventions and diagnostics in Alzheimer's disease and related conditions. American Journal of Alzheimer's Disease and Other Dementias. 25: 107-8. PMID 20229623 DOI: 10.1177/1533317510363778 |
0.373 |
|
| 2010 |
Lippa CF. Focusing on the caregiver: grief in dementia caregiving. American Journal of Alzheimer's Disease and Other Dementias. 25: 7-8. PMID 20183890 DOI: 10.1177/1533317510361313 |
0.351 |
|
| 2010 |
Lippa CF. Review of Issue: Nonpharmaceutical and Pharmaceutical Interventions for Dementia Patients American Journal of Alzheimers Disease and Other Dementias. 25: 625-626. DOI: 10.1177/1533317510390047 |
0.352 |
|
| 2009 |
Lippa CF, Rosso AL, Stutzbach LD, Neumann M, Lee VM, Trojanowski JQ. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Archives of Neurology. 66: 1483-8. PMID 20008652 DOI: 10.1001/Archneurol.2009.277 |
0.419 |
|
| 2009 |
Lippa CF. Barriers to hospice in patients with Alzheimer. American Journal of Alzheimer's Disease and Other Dementias. 24: 443-4. PMID 19938321 DOI: 10.1177/1533317509354907 |
0.381 |
|
| 2009 |
Lippa CF. Primary progressive aphasia and caregiver issues. American Journal of Alzheimer's Disease and Other Dementias. 24: 371-2. PMID 19810201 DOI: 10.1177/1533317509347288 |
0.3 |
|
| 2009 |
Gliebus G, Rosso A, Lippa CF. Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier. American Journal of Alzheimer's Disease and Other Dementias. 24: 456-60. PMID 19776335 DOI: 10.1177/1533317509346209 |
0.351 |
|
| 2009 |
Lippa CF. Compensating for Alzheimer lesions: evidence that size counts. Neurology. 73: 656-7. PMID 19641170 DOI: 10.1212/Wnl.0B013E3181B61B4C |
0.369 |
|
| 2009 |
Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL. Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Research. 1292: 191-8. PMID 19635471 DOI: 10.1016/J.Brainres.2009.07.056 |
0.317 |
|
| 2009 |
Hanson JC, Lippa CF. Lewy body dementia. International Review of Neurobiology. 84: 215-28. PMID 19501720 DOI: 10.1016/S0074-7742(09)00411-5 |
0.464 |
|
| 2009 |
Lippa CF. Clinical characterization in Alzheimer disease. American Journal of Alzheimer's Disease and Other Dementias. 24: 83-4. PMID 19455731 DOI: 10.1177/1533317509333048 |
0.396 |
|
| 2009 |
Revuelta GJ, Lippa CF. Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities. International Psychogeriatrics / Ipa. 21: 213-6. PMID 19173761 DOI: 10.1017/S1041610208008600 |
0.432 |
|
| 2009 |
Irwin D, Lippa CF, Rosso A. Progranulin (PGRN) expression in ALS: an immunohistochemical study. Journal of the Neurological Sciences. 276: 9-13. PMID 18848708 DOI: 10.1016/J.Jns.2008.08.024 |
0.314 |
|
| 2009 |
Lippa CF. Review of Issue: The Use and Abuse of Telephone Screening Interviews for Dementia and Elderspeak: Are We Talking Down to Our Patients? American Journal of Alzheimers Disease and Other Dementias. 24: 7-8. DOI: 10.1177/1533317508330236 |
0.32 |
|
| 2009 |
Lippa CF. Review of Issue: Diagnosis, Treatment, and Referral Issues Related to Dementia: Do You Need a Specialist? American Journal of Alzheimers Disease and Other Dementias. 23: 511-512. DOI: 10.1177/1533317508327283 |
0.333 |
|
| 2009 |
Sadhu I, Rosso AL, Lippa CF, Liu L. Cardiometabolic Complications in Patients With Dementia Annals of Epidemiology. 19: 670. DOI: 10.1016/J.Annepidem.2009.07.032 |
0.369 |
|
| 2008 |
Rosso A, Mossey J, Lippa CF. Caffeine: neuroprotective functions in cognition and Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 23: 417-22. PMID 19230121 DOI: 10.1177/1533317508320083 |
0.408 |
|
| 2008 |
Revuelta GJ, Rosso A, Lippa CF. Association between progranulin and beta-amyloid in dementia with Lewy bodies. American Journal of Alzheimer's Disease and Other Dementias. 23: 488-93. PMID 18955727 DOI: 10.1177/1533317508321910 |
0.38 |
|
| 2008 |
Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. Plos Genetics. 4: e1000193. PMID 18802454 DOI: 10.1371/Journal.Pgen.1000193 |
0.315 |
|
| 2008 |
Revuelta GJ, Rosso A, Lippa CF. Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies. American Journal of Alzheimer's Disease and Other Dementias. 23: 97-102. PMID 18276962 DOI: 10.1177/1533317507310565 |
0.362 |
|
| 2008 |
Gong Y, Rosso AL, Lippa CF. P4-267: Proteomic analysis of synapse reveals the pathogenic protein interactions in Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2336 |
0.338 |
|
| 2007 |
Lippa CF, Knopman DS. Dementia: many roads, but not built in a day. Neurology. 69: 2193-4. PMID 18071139 DOI: 10.1212/01.Wnl.0000287144.13726.3E |
0.376 |
|
| 2007 |
Irwin D, Lippa CF, Swearer JM. Cognition and amyotrophic lateral sclerosis (ALS). American Journal of Alzheimer's Disease and Other Dementias. 22: 300-12. PMID 17712161 DOI: 10.1177/1533317507301613 |
0.354 |
|
| 2007 |
Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6174-84. PMID 17553989 DOI: 10.1523/Jneurosci.0730-07.2007 |
0.362 |
|
| 2007 |
Haleem K, Lippa CF, Smith TW, Kowa H, Wu J, Iwatsubo T. Presenilin-1 C410Y Alzheimer disease plaques contain synaptic proteins. American Journal of Alzheimer's Disease and Other Dementias. 22: 137-44. PMID 17545141 DOI: 10.1177/1533317506298051 |
0.354 |
|
| 2007 |
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.Wnl.0000256715.13907.D3 |
0.367 |
|
| 2006 |
Lippa CF, Emre M. Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys? Neurology. 67: 1910-1. PMID 17159092 DOI: 10.1212/01.Wnl.0000250234.72903.37 |
0.437 |
|
| 2006 |
Lippa CF. An individualized approach to treatment for alzheimer's disease, pick's disease, and other dementias. American Journal of Alzheimer's Disease and Other Dementias. 21: 354-9. PMID 17062555 DOI: 10.1177/1533317506292372 |
0.388 |
|
| 2006 |
Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 866-72. PMID 16957580 DOI: 10.1097/01.Jnen.0000228205.19915.20 |
0.399 |
|
| 2006 |
Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, Tian J, Bigio EH, Ghetti B, Murrell JR, Delisle MB, Mirra S, Crain B, Zolo P, Arima K, Iseki E, ... ... Lippa C, et al. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropathology and Applied Neurobiology. 32: 374-87. PMID 16866983 DOI: 10.1111/J.1365-2990.2006.00736.X |
0.402 |
|
| 2006 |
Lippa CF, Morris JC. Alzheimer neuropathology in nondemented aging: keeping mind over matter. Neurology. 66: 1801-2. PMID 16801639 DOI: 10.1212/01.Wnl.0000234879.82633.F3 |
0.399 |
|
| 2006 |
de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathologica. 111: 329-40. PMID 16552612 DOI: 10.1007/S00401-006-0048-X |
0.341 |
|
| 2006 |
Murray C, Viehman A, Lippa CF. The corpus callosum in Pick's disease, Alzheimer's disease, and amyotrophic lateral sclerosis: gliosis implies possible clinical consequence. American Journal of Alzheimer's Disease and Other Dementias. 21: 37-43. PMID 16526588 DOI: 10.1177/153331750602100111 |
0.457 |
|
| 2006 |
Nagarsheth MH, Viehman A, Lippa SM, Lippa CF. Notch-1 immunoexpression is increased in Alzheimer's and Pick's disease. Journal of the Neurological Sciences. 244: 111-6. PMID 16473372 DOI: 10.1016/J.Jns.2006.01.007 |
0.407 |
|
| 2006 |
Leverenz JB, Berman S, Galasko DR, Bekris LM, Galvin JE, Goldman J, Irwin D, Kaufer D, Lippa C, Litvan I, Long A, Lopez OL, Tsuang D, Zabetian CP. P3-214: DEMENTIA WITH LEWY BODIES CONSORTIUM: METHODOLOGY AND INITIAL SUBJECT CHARACTERISTICS Alzheimer's & Dementia. 14: P1152-P1153. DOI: 10.1016/J.Jalz.2018.06.1573 |
0.324 |
|
| 2005 |
Lippa SM, Lippa CF, Mori H. Alpha-Synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. American Journal of Alzheimer's Disease and Other Dementias. 20: 315-8. PMID 16273997 DOI: 10.1177/153331750502000506 |
0.349 |
|
| 2005 |
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1 |
0.401 |
|
| 2004 |
Lippa CF. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies. American Journal of Alzheimer's Disease and Other Dementias. 19: 341-4. PMID 15633942 DOI: 10.1177/153331750401900606 |
0.426 |
|
| 2004 |
Popescu A, Lippa CF, Lee VM, Trojanowski JQ. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Archives of Neurology. 61: 1915-9. PMID 15596612 DOI: 10.1001/Archneur.61.12.1915 |
0.351 |
|
| 2004 |
Nee LE, Tierney MC, Lippa CF. Genetic aspects of Alzheimer's disease, Pick's disease, and other dementias. American Journal of Alzheimer's Disease and Other Dementias. 19: 219-25. PMID 15359559 DOI: 10.1177/153331750401900412 |
0.348 |
|
| 2004 |
Nunomura A, Chiba S, Lippa CF, Cras P, Kalaria RN, Takeda A, Honda K, Smith MA, Perry G. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiology of Disease. 17: 108-13. PMID 15350971 DOI: 10.1016/J.Nbd.2004.06.003 |
0.336 |
|
| 2004 |
Lippa CF, Dickson DW. Hippocampal sclerosis dementia: expanding the phenotypes of frontotemporal dementias? Neurology. 63: 414-5. PMID 15304570 DOI: 10.1212/01.Wnl.0000136241.71716.72 |
0.356 |
|
| 2004 |
McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, et al. Dementia with Lewy bodies. The Lancet. Neurology. 3: 19-28. PMID 14693108 DOI: 10.1016/S1474-4422(03)00619-7 |
0.341 |
|
| 2004 |
Lippa CF. P3-341 Synaptophysin immunoreactivity in pick's disease: comparison with Alzheimer's disease and dementia with lewy bodies Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81490-8 |
0.421 |
|
| 2004 |
Popescu A, Lippa CF. Parkinsonian syndromes: Parkinson's disease dementia, dementia with Lewy bodies and progressive supranuclear palsy Clinical Neuroscience Research. 3: 461-468. DOI: 10.1016/J.Cnr.2004.04.011 |
0.424 |
|
| 2003 |
Lippa CF, McKeith I. Dementia with Lewy bodies: improving diagnostic criteria. Neurology. 60: 1571-2. PMID 12771241 DOI: 10.1212/01.Wnl.0000066054.20031.B0 |
0.387 |
|
| 2003 |
Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathologica. 105: 469-76. PMID 12677447 DOI: 10.1007/S00401-002-0668-8 |
0.381 |
|
| 2003 |
Popescu A, Lippa CF. Book Review: Drug Discovery and Development for Alzheimer's Disease 2000 American Journal of Alzheimers Disease and Other Dementias. 18: 126-128. DOI: 10.1177/153331750301800209 |
0.346 |
|
| 2002 |
Rogan S, Lippa CF. Alzheimer's disease and other dementias: a review. American Journal of Alzheimer's Disease and Other Dementias. 17: 11-7. PMID 11831415 DOI: 10.1177/153331750201700106 |
0.427 |
|
| 2001 |
Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease. Archives of Neurology. 58: 1817-20. PMID 11708989 DOI: 10.1001/Archneur.58.11.1817 |
0.366 |
|
| 2001 |
Cataldo A, Rebeck GW, Ghetri B, Hulette C, Lippa C, Van Broeckhoven C, van Duijn C, Cras P, Bogdanovic N, Bird T, Peterhoff C, Nixon R. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders. Annals of Neurology. 50: 661-5. PMID 11706973 DOI: 10.1002/Ana.1254 |
0.413 |
|
| 2001 |
Shafiq M, Nee L, Grafman J, Tresser N, Lee VM, Trojanowski JQ, Lippa CF. Frontotemporal dementia: report of a familial case. Neurology. 56: S31-4. PMID 11402148 DOI: 10.1212/Wnl.56.Suppl_4.S31 |
0.341 |
|
| 2001 |
Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, et al. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition. Neurobiology of Aging. 22: 367-76. PMID 11378241 DOI: 10.1016/S0197-4580(01)00216-0 |
0.349 |
|
| 2001 |
Nee LE, Lippa CF. Inherited Alzheimer's disease PS-1 olfactory function: a 10-year follow-up study. American Journal of Alzheimer's Disease and Other Dementias. 16: 83-4. PMID 11302075 DOI: 10.1177/153331750101600210 |
0.392 |
|
| 2000 |
Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa CF, Ono S, Okazawa H. JNK activation is associated with intracellular beta-amyloid accumulation. Brain Research. Molecular Brain Research. 85: 221-33. PMID 11146125 DOI: 10.1016/S0169-328X(00)00245-X |
0.312 |
|
| 2000 |
Mathews PM, Cataldo AM, Kao BH, Rudnicki AG, Qin X, Yang JL, Jiang Y, Picciano M, Hulette C, Lippa CF, Bird TD, Nochlin D, Walter J, Haass C, Lévesque L, et al. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Molecular Medicine (Cambridge, Mass.). 6: 878-91. PMID 11126202 DOI: 10.1007/Bf03401825 |
0.392 |
|
| 2000 |
Lippa CF, Zhukareva V, Kawarai T, Uryu K, Shafiq M, Nee LE, Grafman J, Liang Y, St George-Hyslop PH, Trojanowski JQ, Lee VM. Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation. Annals of Neurology. 48: 850-8. PMID 11117541 DOI: 10.1002/1531-8249(200012)48:6<850::Aid-Ana5>3.0.Co;2-V |
0.321 |
|
| 2000 |
Lippa CF, Swearer JM, Kane KJ, Nochlin D, Bird TD, Ghetti B, Nee LE, St George-Hyslop P, Pollen DA, Drachman DA. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Annals of Neurology. 48: 376-9. PMID 10976645 DOI: 10.1002/1531-8249(200009)48:3<376::Aid-Ana13>3.0.Co;2-U |
0.386 |
|
| 2000 |
Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B, Gambetti P, Tabaton M, Teller JK. Presenilin-1 mutations in Alzheimer's disease. Nature. 405: 531-2. PMID 10850703 DOI: 10.1038/35014735 |
0.382 |
|
| 2000 |
Lippa CF, Schmidt ML, Nee LE, Bird T, Nochlin D, Hulette C, Mori H, Lee VM, Trojanowski JQ. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease. Neurology. 54: 100-4. PMID 10636133 DOI: 10.1212/Wnl.54.1.100 |
0.383 |
|
| 2000 |
Mehring B, Lin JCY, Wilson D, Lippa CF. Frontotemporal dementia with ubiquitinated inclusions: A case study of the regional distribution of hippocampal pathology American Journal of Alzheimers Disease and Other Dementias. 15: 277-283. DOI: 10.1177/153331750001500507 |
0.333 |
|
| 2000 |
Lippa CF, Nee L, Pollen D, Lee V, Trojanowski JQ. Lewy bodies may influence symptomatology in some cases of presenilin-related Alzheimer's disease Neurobiology of Aging. 21: 38. DOI: 10.1016/S0197-4580(00)82848-1 |
0.388 |
|
| 1999 |
Lippa CF, Ozawa K, Mann DM, Ishii K, Smith TW, Arawaka S, Mori H. Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease. Archives of Neurology. 56: 1111-8. PMID 10488812 DOI: 10.1001/Archneur.56.9.1111 |
0.429 |
|
| 1999 |
Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Annals of Neurology. 45: 353-7. PMID 10072050 DOI: 10.1002/1531-8249(199903)45:3<353::Aid-Ana11>3.0.Co;2-4 |
0.323 |
|
| 1998 |
Lippa CF, Flanders KC, Kim ES, Croul S. TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy. Neurobiology of Aging. 19: 527-33. PMID 10192211 DOI: 10.1016/S0197-4580(98)00089-X |
0.31 |
|
| 1998 |
Lippa CF, Johnson R, Smith TW. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Annals of Neurology. 43: 102-6. PMID 9450774 DOI: 10.1002/ana.410430117 |
0.317 |
|
| 1998 |
Lippa CF, Smith TW, Swearer J. Dementia with parkinsonism: Alzheimer's disease is more common than dementia with Lewy bodies American Journal of Alzheimers Disease and Other Dementias. 13: 229-235. DOI: 10.1177/153331759801300503 |
0.458 |
|
| 1995 |
Smith TW, Lippa CF. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. Journal of Neuropathology and Experimental Neurology. 54: 297-303. PMID 7745428 |
0.312 |
|
| 1995 |
Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Archives of Neurology. 52: 1074-9. PMID 7487559 DOI: 10.1001/Archneur.1995.00540350068018 |
0.324 |
|
| 1992 |
Drachman DA, Lippa CF. The etiology of Alzheimer's disease: the pathogenesis of dementia. The role of neurotoxins. Annals of the New York Academy of Sciences. 648: 176-86. PMID 1637045 |
0.346 |
|
| Show low-probability matches. |